aluates Reports

$ 0.0

Automative

Global Cancer Genomic Testing Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-37A5716

Global Cancer Genomic Testing Market Insights Forecast to 2028

BUY CHAPTERS

Global Cancer Genomic Testing Market Research Report 2025

Code: QYRE-Auto-37A5716

Report

June 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Myriad Genetics

CENTOGENE

Color Genomics

Quest Diagnostics

23andMe

Gene By Gene Ltd.

LabCorp

Positive Bioscience

Bio Rad Laboratories

Illumina Inc

Agilent Technologies

Thermo Fisher Scientific

Cancer Genomic Testing Market

The global market for Cancer Genomic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Cancer Genomic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cancer Genomic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cancer Genomic Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cancer Genomic Testing include Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience, Bio-Rad Laboratories, Illumina, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Genomic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genomic Testing.

The Cancer Genomic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Genomic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Genomic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Genomic Testing Market Report

Report Metric	Details
Report Name	Cancer Genomic Testing Market
Segment by Type	Breast Cancer Genomic Testing Lung Cancer Genomic Testing Blood Cancer Genomic Testing Liver Cancer Genomic Testing Stomach Cancer Genomic Testing Others
Segment by Application	Hospitals Clinics Diagnostic Laboratories Academic and Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience, Bio-Rad Laboratories, Illumina, Inc., Agilent Technologies, Thermo Fisher Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genomic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Genomic Testing Market report?

Ans: The main players in the Cancer Genomic Testing Market are Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience, Bio-Rad Laboratories, Illumina, Inc., Agilent Technologies, Thermo Fisher Scientific

What are the Application segmentation covered in the Cancer Genomic Testing Market report?

Ans: The Applications covered in the Cancer Genomic Testing Market report are Hospitals, Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others

What are the Type segmentation covered in the Cancer Genomic Testing Market report?

Ans: The Types covered in the Cancer Genomic Testing Market report are Breast Cancer Genomic Testing, Lung Cancer Genomic Testing, Blood Cancer Genomic Testing, Liver Cancer Genomic Testing, Stomach Cancer Genomic Testing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Breast Cancer Genomic Testing

1.2.3 Lung Cancer Genomic Testing

1.2.4 Blood Cancer Genomic Testing

1.2.5 Liver Cancer Genomic Testing

1.2.6 Stomach Cancer Genomic Testing

1.2.7 Others

1.3 Market by Application

1.3.1 Global Cancer Genomic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Diagnostic Laboratories

1.3.5 Academic and Research Institutes

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Genomic Testing Market Perspective (2020-2031)

2.2 Global Cancer Genomic Testing Growth Trends by Region

2.2.1 Global Cancer Genomic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Genomic Testing Historic Market Size by Region (2020-2025)

2.2.3 Cancer Genomic Testing Forecasted Market Size by Region (2026-2031)

2.3 Cancer Genomic Testing Market Dynamics

2.3.1 Cancer Genomic Testing Industry Trends

2.3.2 Cancer Genomic Testing Market Drivers

2.3.3 Cancer Genomic Testing Market Challenges

2.3.4 Cancer Genomic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Genomic Testing Players by Revenue

3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2020-2025)

3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Genomic Testing Revenue

3.4 Global Cancer Genomic Testing Market Concentration Ratio

3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2024

3.5 Global Key Players of Cancer Genomic Testing Head office and Area Served

3.6 Global Key Players of Cancer Genomic Testing, Product and Application

3.7 Global Key Players of Cancer Genomic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genomic Testing Breakdown Data by Type

4.1 Global Cancer Genomic Testing Historic Market Size by Type (2020-2025)

4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2026-2031)

5 Cancer Genomic Testing Breakdown Data by Application

5.1 Global Cancer Genomic Testing Historic Market Size by Application (2020-2025)

5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Genomic Testing Market Size (2020-2031)

6.2 North America Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Genomic Testing Market Size by Country (2020-2025)

6.4 North America Cancer Genomic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Genomic Testing Market Size (2020-2031)

7.2 Europe Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Genomic Testing Market Size by Country (2020-2025)

7.4 Europe Cancer Genomic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Genomic Testing Market Size (2020-2031)

8.2 Asia-Pacific Cancer Genomic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Genomic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Genomic Testing Market Size (2020-2031)

9.2 Latin America Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Genomic Testing Market Size by Country (2020-2025)

9.4 Latin America Cancer Genomic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Genomic Testing Market Size (2020-2031)

10.2 Middle East & Africa Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Genomic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Details

11.1.2 Myriad Genetics Business Overview

11.1.3 Myriad Genetics Cancer Genomic Testing Introduction

11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2020-2025)

11.1.5 Myriad Genetics Recent Development

11.2 Centogene AG

11.2.1 Centogene AG Company Details

11.2.2 Centogene AG Business Overview

11.2.3 Centogene AG Cancer Genomic Testing Introduction

11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2020-2025)

11.2.5 Centogene AG Recent Development

11.3 Color Genomics

11.3.1 Color Genomics Company Details

11.3.2 Color Genomics Business Overview

11.3.3 Color Genomics Cancer Genomic Testing Introduction

11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2020-2025)

11.3.5 Color Genomics Recent Development

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Details

11.4.2 Quest Diagnostics Business Overview

11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction

11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2020-2025)

11.4.5 Quest Diagnostics Recent Development

11.5 23andMe Inc.

11.5.1 23andMe Inc. Company Details

11.5.2 23andMe Inc. Business Overview

11.5.3 23andMe Inc. Cancer Genomic Testing Introduction

11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2020-2025)

11.5.5 23andMe Inc. Recent Development

11.6 Gene By Gene Ltd.

11.6.1 Gene By Gene Ltd. Company Details

11.6.2 Gene By Gene Ltd. Business Overview

11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction

11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2020-2025)

11.6.5 Gene By Gene Ltd. Recent Development

11.7 LabCorp

11.7.1 LabCorp Company Details

11.7.2 LabCorp Business Overview

11.7.3 LabCorp Cancer Genomic Testing Introduction

11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2020-2025)

11.7.5 LabCorp Recent Development

11.8 Positive Bioscience

11.8.1 Positive Bioscience Company Details

11.8.2 Positive Bioscience Business Overview

11.8.3 Positive Bioscience Cancer Genomic Testing Introduction

11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2020-2025)

11.8.5 Positive Bioscience Recent Development

11.9 Bio-Rad Laboratories

11.9.1 Bio-Rad Laboratories Company Details

11.9.2 Bio-Rad Laboratories Business Overview

11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction

11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2020-2025)

11.9.5 Bio-Rad Laboratories Recent Development

11.10 Illumina, Inc.

11.10.1 Illumina, Inc. Company Details

11.10.2 Illumina, Inc. Business Overview

11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction

11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2020-2025)

11.10.5 Illumina, Inc. Recent Development

11.11 Agilent Technologies

11.11.1 Agilent Technologies Company Details

11.11.2 Agilent Technologies Business Overview

11.11.3 Agilent Technologies Cancer Genomic Testing Introduction

11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2020-2025)

11.11.5 Agilent Technologies Recent Development

11.12 Thermo Fisher Scientific

11.12.1 Thermo Fisher Scientific Company Details

11.12.2 Thermo Fisher Scientific Business Overview

11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction

11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2020-2025)

11.12.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Myriad Genetics

CENTOGENE

Color Genomics

Quest Diagnostics

23andMe

Gene By Gene Ltd.

LabCorp

Positive Bioscience

Bio Rad Laboratories

Illumina Inc

Agilent Technologies

Thermo Fisher Scientific

List of Tables

Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Breast Cancer Genomic Testing

Table 3. Key Players of Lung Cancer Genomic Testing

Table 4. Key Players of Blood Cancer Genomic Testing

Table 5. Key Players of Liver Cancer Genomic Testing

Table 6. Key Players of Stomach Cancer Genomic Testing

Table 7. Key Players of Others

Table 8. Global Cancer Genomic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Cancer Genomic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Cancer Genomic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Cancer Genomic Testing Market Share by Region (2020-2025)

Table 12. Global Cancer Genomic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Cancer Genomic Testing Market Share by Region (2026-2031)

Table 14. Cancer Genomic Testing Market Trends

Table 15. Cancer Genomic Testing Market Drivers

Table 16. Cancer Genomic Testing Market Challenges

Table 17. Cancer Genomic Testing Market Restraints

Table 18. Global Cancer Genomic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Cancer Genomic Testing Market Share by Players (2020-2025)

Table 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2024)

Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Cancer Genomic Testing, Headquarters and Area Served

Table 24. Global Key Players of Cancer Genomic Testing, Product and Application

Table 25. Global Key Players of Cancer Genomic Testing, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Cancer Genomic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2020-2025)

Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2026-2031)

Table 31. Global Cancer Genomic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Cancer Genomic Testing Revenue Market Share by Application (2020-2025)

Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Cancer Genomic Testing Revenue Market Share by Application (2026-2031)

Table 35. North America Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Cancer Genomic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Cancer Genomic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Cancer Genomic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 50. Myriad Genetics Company Details

Table 51. Myriad Genetics Business Overview

Table 52. Myriad Genetics Cancer Genomic Testing Product

Table 53. Myriad Genetics Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 54. Myriad Genetics Recent Development

Table 55. Centogene AG Company Details

Table 56. Centogene AG Business Overview

Table 57. Centogene AG Cancer Genomic Testing Product

Table 58. Centogene AG Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 59. Centogene AG Recent Development

Table 60. Color Genomics Company Details

Table 61. Color Genomics Business Overview

Table 62. Color Genomics Cancer Genomic Testing Product

Table 63. Color Genomics Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 64. Color Genomics Recent Development

Table 65. Quest Diagnostics Company Details

Table 66. Quest Diagnostics Business Overview

Table 67. Quest Diagnostics Cancer Genomic Testing Product

Table 68. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 69. Quest Diagnostics Recent Development

Table 70. 23andMe Inc. Company Details

Table 71. 23andMe Inc. Business Overview

Table 72. 23andMe Inc. Cancer Genomic Testing Product

Table 73. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 74. 23andMe Inc. Recent Development

Table 75. Gene By Gene Ltd. Company Details

Table 76. Gene By Gene Ltd. Business Overview

Table 77. Gene By Gene Ltd. Cancer Genomic Testing Product

Table 78. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 79. Gene By Gene Ltd. Recent Development

Table 80. LabCorp Company Details

Table 81. LabCorp Business Overview

Table 82. LabCorp Cancer Genomic Testing Product

Table 83. LabCorp Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 84. LabCorp Recent Development

Table 85. Positive Bioscience Company Details

Table 86. Positive Bioscience Business Overview

Table 87. Positive Bioscience Cancer Genomic Testing Product

Table 88. Positive Bioscience Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 89. Positive Bioscience Recent Development

Table 90. Bio-Rad Laboratories Company Details

Table 91. Bio-Rad Laboratories Business Overview

Table 92. Bio-Rad Laboratories Cancer Genomic Testing Product

Table 93. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 94. Bio-Rad Laboratories Recent Development

Table 95. Illumina, Inc. Company Details

Table 96. Illumina, Inc. Business Overview

Table 97. Illumina, Inc. Cancer Genomic Testing Product

Table 98. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 99. Illumina, Inc. Recent Development

Table 100. Agilent Technologies Company Details

Table 101. Agilent Technologies Business Overview

Table 102. Agilent Technologies Cancer Genomic Testing Product

Table 103. Agilent Technologies Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 104. Agilent Technologies Recent Development

Table 105. Thermo Fisher Scientific Company Details

Table 106. Thermo Fisher Scientific Business Overview

Table 107. Thermo Fisher Scientific Cancer Genomic Testing Product

Table 108. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 109. Thermo Fisher Scientific Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Authors List of This Report

List of Figures

Figure 1. Cancer Genomic Testing Picture

Figure 2. Global Cancer Genomic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Genomic Testing Market Share by Type: 2024 VS 2031

Figure 4. Breast Cancer Genomic Testing Features

Figure 5. Lung Cancer Genomic Testing Features

Figure 6. Blood Cancer Genomic Testing Features

Figure 7. Liver Cancer Genomic Testing Features

Figure 8. Stomach Cancer Genomic Testing Features

Figure 9. Others Features

Figure 10. Global Cancer Genomic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Cancer Genomic Testing Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Clinics Case Studies

Figure 14. Diagnostic Laboratories Case Studies

Figure 15. Academic and Research Institutes Case Studies

Figure 16. Others Case Studies

Figure 17. Cancer Genomic Testing Report Years Considered

Figure 18. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Cancer Genomic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Cancer Genomic Testing Market Share by Region: 2024 VS 2031

Figure 21. Global Cancer Genomic Testing Market Share by Players in 2024

Figure 22. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2024

Figure 24. North America Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 26. United States Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 30. Germany Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Cancer Genomic Testing Market Share by Region (2020-2031)

Figure 38. China Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 46. Mexico Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 50. Turkey Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 54. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 55. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 56. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 57. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 58. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 59. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 60. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 62. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 63. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lung Cancer Genomic Testing Market Research Report 2024

Global Cancer Oncology Testing Market Research Report 2024

Global Next Generation Tumor Genetic Testing Market Research Report 2024

Global Genomic Biomarkers Market Research Report 2024

Global Inherited Cancer Genome Testing Market Research Report 2024

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Predictive Genetic Testing And Consumer Genomics Market Research Report 2024

Global Tumor Biomarker Test Market Research Report 2024

Global Genotyping Test Market Research Report 2025

Global Tumor Gene Test Service Market Research Report 2025

Global DNA Genetic Testing Market Research Report 2024

Global Genomics Services Market Research Report 2024

Cancer Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Genome Sequencing Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Cancer Screening Technology Market Research Report 2024

Next Generation Cancer Diagnostics Market

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions